Announcement the resolution by the Company's
Board of Directors to reinvest equity on behalf of
subsidiary MKS
Date of events
2022/08/04
To which item it meets
paragraph 20
Statement
1.Name and nature of the underlying assets (if preferred shares,
the terms and conditions of issuance shall also be indicated,
e.g., dividend yield, etc.):
acquire 100% equity of
SIN KANG TCM CLINIC(PL) PTE. LTD. and
SIN KANG TCM CLINIC PTE. LTD.
2.Date of occurrence of the event:2022/08/04
3.Volume, unit price, and total monetary amount of the transaction:
Supplementary announcement after the contract is signed
4.Trading counterparty and its relationship to the Company
(if the trading counterparty is a natural person and
furthermore is not a related party of the Company, the name
of the trading counterparty is not required to be disclosed):
(1)Trading counterparty:natural person
(2)its relationship to the Company:not a related party
5.Where the trading counterparty is a related party,
announcement shall also be made of the reason for choosing
the related party as trading counterparty and the
identity of the previous owner, its relationship with
the Company and the trading counterparty, and the previous
date and monetary value of transfer:
NA
6.Where an owner of the underlying assets within the past
five years has been an related party of the Company, the
announcement shall also include the date and price of
acquisition and disposal by the related party, and its
relationship to the Company at the time of the transaction:
NA
7.Matters related to the current disposal of creditors'
rights (including types of collaterals of the disposed
creditor's rights; if creditor's rights over a related
party, announcement shall be made of the name of the
related party and the book amount of the creditor's
rights, currently being disposed of, over such related
party:NA
8.Profit or loss from the disposal (not applicable in
cases of acquisition of securities) (where originally
deferred, the status of recognition shall be listed and
explained):
NA
9.Terms of delivery or payment (including payment period
and monetary value), restrictive covenants in the contract,
and other important terms and conditions:
Supplementary announcement after the contract is signed
10.The manner in which the current transaction was
decided, the reference basis for the decision on price,
and the decision-making unit:
Decision making process and pricing: The price was
decided by mutual consent and expert evaluation report.
Decision-making unit: Board of Directors
11.Net worth per share of the Company's underlying securities
acquired or disposed of:
NA
12.Cumulative no.of shares held (including the current
transaction), their monetary value, shareholding percentage,
and status of any restriction of rights (e.g., pledges),
as of the present moment:
Supplementary announcement after the contract is signed
13.Ratio of securities investment (including the current
transaction) to the total assets and shareholder's equity
of the parent company on the latest financial statements,
and the operating capital on the latest financial statements,
as of the present moment:
Supplementary announcement after the contract is signed
14.Broker and broker's fee:NA
15.Concrete purpose or use of the acquisition or disposal:
Singapore Entities to expand on clinics
16.Whether the directors expressed any objection to the current
transaction:None
17.Whether the counterparty of the current transaction
is a related party:No
18.Date of the Board of Directors' resolution:NA
19.Date of ratification by supervisors or approval by
the Audit Committee:NA
20.Whether the CPA issued an opinion on the unreasonableness
regarding the current transaction:
No
21.Name of the CPA firm:
Good Idea CPA Firm
22.Name of the CPA:
Wu Ming ying
23.License no.of the CPA:
License no.5986
24.Any other matters that need to be specified:
The Singapore exchange rate is 21.4033
Attachments
Original Link
Original Document
Permalink
Disclaimer
Ma Kuang Healthcare Holding Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 12:17:06 UTC.
Ma Kuang Healthcare Holding Limited is a Cayman Islands-based medical service provider. The Company provides services, including Traditional Chinese Medicine (TCM), western medicine, medical cosmetology, health management, medication and health products. The Companyâs businesses include Singapore TCM Clinics, Tianjin Makuang Medical Chain, and Herbs Retail. Its Singapore TCM Clinics business operates approximately 20 TCM clinics and TuiNa centres distributed islandwide. The business offers various treatments, including TCM Consultation, Acupuncture, TuiNa Therapy, Cupping, Gua Sha/ Scrapping and TDP Lamp. It also provides Chinese medicinal powders, healthcare products and Chinese proprietary medicine. Tianjin Makuang Medical Chain business includes Medicare insurance designated community hospitals and medical cosmetology specialist hospitals. Herbs Retail business offers traditional Chinese herbs, such as birdâs nest, Ginseng, Antler horn, Ganoderma lucidum (LingZhi), and others.
MA KUANG HEALTHCARE HOLDING LIMITED 